The primary goals of this clinical trial are to evaluate the safety and efficacy of a low dose whole-heart radiotherapy with a single fraction in ten participants with advanced heart failure.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Change from Baseline in the Left Ventricular Ejection Fraction
Timeframe: 4 weeks after radiotherapy
Treatment-related Adverse Effects as assessed by CTCAE v5.0
Timeframe: Evaluation at 2, 4, 12 weeks and every 6 months unti 5 years after radiotherapy